据安迅思伦敦5月31日消息，朗盛公司和Advent公司周二表示，两家公司将收购荷兰专用化学品公司帝斯曼旗下工程材料部门，并打算将该部门与朗盛自己的高性能材料业务合并。

在帝斯曼宣布计划与总部位于瑞士的香精香料公司Firmenich合并数小时后，这家荷兰公司同意出售其工程材料业务，标志着该公司最终转型为一家健康、营养和生物科学专业公司。

Advent将支付约37亿欧元收购帝斯曼工程材料业务。帝斯曼工程材料业务将与朗盛公司旗下高性能材料业务合并成立一家合资公司，总部位于美国的私人股本公司Advent将成为合资公司的控股股东。

两家公司表示，Advent将向朗盛额外支付11亿欧元，朗盛公司将在合资公司中持有约40%的股份。

这笔交易预计将于2023年上半年完成，合并后的帝斯曼/朗盛业务预计将实现约30亿欧元的年销售额。

庞晓华 摘译自 ICIS

原文如下：

LANXESS, Advent to acquire DSM engineering materials arm, establish joint 

LANXESS and Advent are to acquire the engineering materials division of Netherlands-based specialties player DSM, the companies said on Tuesday, with an eye to merging the operations with LANXESS’ own high-performance materials business.

Coming hours after an announcement by DSM of plans to merge with Switzerland-based flavours and fragrances player Firmenich, the Dutch company agreed to sell its engineering materials business, signalling its final transformation into a health, nutrition, and biosciences specialist.

Advent is to pay around 3.7bn for the DSM business, which is to be folded into a joint venture with LANXESS high-performance materials business, with the US-headquartered private equity firm to stand as the majority owner of the combined operations.

Advent is to pay out an additional 1.1bn to LANXESS, with the Germany-based chemicals business to hold a stake of around 40% in the joint venture, the companies said.

The deal is expected to close in the first half of 2023, with the combined DSM/LANXESS business expected to have combined annual sales of around 3bn.